This model integrates ethical considerations and methodological rigor in biomedical funding, suggesting scalable approaches for funders.
Patient and carer perspectives, methodological rigor, and ethical considerations can all be successfully integrated into the biomedical funding process. Drawing on experiences with ERA-NET NEURON, we present a structured, scalable, and transferable model for funders to follow.
No takes yet. Share an insight, caveat, or question.
Müller et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: